Kintayl Capital LP decreased its stake in Sotera Health Company (NASDAQ:SHC - Free Report) by 49.5% in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 419,796 shares of the company's stock after selling 410,792 shares during the quarter. Sotera Health accounts for about 3.5% of Kintayl Capital LP's investment portfolio, making the stock its 12th largest holding. Kintayl Capital LP owned 0.15% of Sotera Health worth $4,895,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds and other institutional investors have also modified their holdings of SHC. Victory Capital Management Inc. boosted its position in Sotera Health by 67.3% during the 4th quarter. Victory Capital Management Inc. now owns 54,549 shares of the company's stock worth $746,000 after acquiring an additional 21,939 shares during the period. PNC Financial Services Group Inc. raised its stake in shares of Sotera Health by 39.4% during the 4th quarter. PNC Financial Services Group Inc. now owns 9,302 shares of the company's stock worth $127,000 after purchasing an additional 2,627 shares in the last quarter. Connor Clark & Lunn Investment Management Ltd. raised its stake in shares of Sotera Health by 128.9% during the 4th quarter. Connor Clark & Lunn Investment Management Ltd. now owns 90,332 shares of the company's stock worth $1,236,000 after purchasing an additional 50,870 shares in the last quarter. Swiss National Bank raised its stake in shares of Sotera Health by 10.9% during the 4th quarter. Swiss National Bank now owns 306,400 shares of the company's stock worth $4,192,000 after purchasing an additional 30,100 shares in the last quarter. Finally, Envestnet Portfolio Solutions Inc. raised its stake in shares of Sotera Health by 17.3% during the 4th quarter. Envestnet Portfolio Solutions Inc. now owns 15,839 shares of the company's stock worth $217,000 after purchasing an additional 2,340 shares in the last quarter. Institutional investors and hedge funds own 91.03% of the company's stock.
Sotera Health Stock Performance
Shares of SHC traded down $0.17 on Friday, reaching $11.06. 1,120,501 shares of the stock traded hands, compared to its average volume of 1,236,871. The firm has a market cap of $3.14 billion, a price-to-earnings ratio of 17.84 and a beta of 1.81. The company has a debt-to-equity ratio of 5.55, a current ratio of 2.46 and a quick ratio of 2.19. Sotera Health Company has a 12 month low of $9.53 and a 12 month high of $17.08. The stock's 50-day moving average price is $11.88 and its 200-day moving average price is $12.19.
Sotera Health (NASDAQ:SHC - Get Free Report) last announced its quarterly earnings results on Thursday, May 1st. The company reported $0.14 EPS for the quarter, beating the consensus estimate of $0.12 by $0.02. The business had revenue of $254.52 million for the quarter, compared to analyst estimates of $245.56 million. Sotera Health had a return on equity of 41.08% and a net margin of 2.24%. Sotera Health's quarterly revenue was up 2.6% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.13 EPS. Equities analysts forecast that Sotera Health Company will post 0.61 EPS for the current fiscal year.
Analyst Ratings Changes
A number of equities research analysts have recently weighed in on the company. Wall Street Zen raised Sotera Health from a "hold" rating to a "buy" rating in a research note on Saturday, June 28th. Piper Sandler reduced their target price on Sotera Health from $15.00 to $13.00 and set a "neutral" rating for the company in a report on Wednesday, April 23rd. The Goldman Sachs Group upgraded Sotera Health from a "neutral" rating to a "buy" rating and boosted their target price for the stock from $14.00 to $17.00 in a report on Monday, May 5th. Finally, Barclays reduced their target price on Sotera Health from $15.00 to $13.00 and set an "overweight" rating for the company in a report on Tuesday, June 24th. One investment analyst has rated the stock with a hold rating and five have given a buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average target price of $16.00.
Read Our Latest Report on SHC
About Sotera Health
(
Free Report)
Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.
Featured Articles
Before you consider Sotera Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sotera Health wasn't on the list.
While Sotera Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
